In a study from Harvell et al, it was observed that individuals with increased mucosal IgA had improved protection from breakthrough infection with the omicron (BA.1) variant of SARS-CoV-2 (19), illustrating the importance of inducing mucosal immunity to curb new waves of infection. The gene discussed is CD79A; the disease is infection.